Recipient organisationNIHR Leicester Biomedical Research Centre
NIHR supportRecorded as supported by this research centre
PeriodFeb 2025 — Oct 2026
In plain English
AI plain-English summary
Endurance athletes face a 2.4-fold higher risk of developing atrial fibrillation (AF), an irregular heart rhythm that raises stroke risk, but doctors do not know why. This case-control study will recruit athletes with and without AF, then use echocardiograms, exercise tests, continuous ECG monitoring, and heart MRI to compare the structure and electrical activity of their hearts. The goal is to identify the specific physical or electrical differences that make some athletes vulnerable. If the researchers succeed, clinicians could screen athletes for those early markers and advise on training loads or other interventions before AF develops. That would reduce stroke risk in a population that otherwise benefits enormously from exercise. The study is observational—it does not test a treatment—so its immediate impact is diagnostic, not therapeutic. But understanding the mechanism is a necessary first step: without knowing why the atria misfire in athletes, any attempt to prevent or treat the condition would be guesswork.
View original technical description
The study will be a case-control study recruiting athletes with and without atrial fibrillation (AF) to phenotype them to look at structural and electrical differences in athletes with and without AF. Athletes are at a 2.4-fold increased risk of developing AF but the mechanisms behind this are not fully understood. The research area is important because athletes with AF pose an increased risk of stroke. AF is characterised by an irregularly fast heart rhythm causing the atria in the heart to contract spontaneously. Sport and exercise are good for the heart and overall health, but at the extreme end in endurance athletes, it appears too much may be bad, increasing the risk of AF. Male and female athletes from any sport over the age of 18 who have previously competed in competitions will be eligible with a history of AF, and no history of AF for athletic controls. The study will involve a single visit to Glenfield Hospital and the study visit will last approximately 4 hours. The participants will undergo venepuncture, electrocardiogram recording, electronic stethoscope recording, CardioSignal recording to measure cardiac motion, echocardiogram, exercise testing, be fitted with a continuous ECG recorder for 72hrs, and a subset to receive heart MRI. All methods are non-invasive, and the study is a case-control study involving no intervention.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know